Surmodics downgraded to Neutral from Buy at Sidoti
PremiumThe FlySurmodics downgraded to Neutral from Buy at Sidoti
2M ago
SurModics Incentivizes Executives Ahead of Merger
PremiumCompany Announcements
SurModics Incentivizes Executives Ahead of Merger
2M ago
Surmodics to be acquired by PE firm GTCR for $43 per share in cash
PremiumThe Fly
Surmodics to be acquired by PE firm GTCR for $43 per share in cash
2M ago
Surmodics Shareholders Approve Directors and Fiscal Oversight
PremiumCompany AnnouncementsSurmodics Shareholders Approve Directors and Fiscal Oversight
6M ago
Surmodics earnings selloff a buying opportunity, says Barrington
PremiumThe Fly
Surmodics earnings selloff a buying opportunity, says Barrington
6M ago
Surmodics ‘methodically preparing for a new phase of growth,’ says Lake Street
PremiumThe Fly
Surmodics ‘methodically preparing for a new phase of growth,’ says Lake Street
6M ago
Surmodics management to meet with Barrington
PremiumThe FlySurmodics management to meet with Barrington
6M ago
Surmodics management to meet with Barrington
PremiumThe Fly
Surmodics management to meet with Barrington
7M ago
Surmodics announces 36-month data from TRANSCEND trial
PremiumThe Fly
Surmodics announces 36-month data from TRANSCEND trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100